ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Mycostatin, suspension buvable/buccale - 24 ml
33043015 Sanofi-Aventis (Suisse) SA
Mycostatin, suspension buvable/buccale18.05.1967
Original18.05.1967
Nystatin (A07AA02)28.08.2007
WHO-DDD 
08.06.24 ml
08.06. 
B  
Yes 
IPCI
2.92No
    
10 %12.35
7680330430154Synthetika
680673 
Composition
nystatinum 100000 U.I., saccharum 500 mg, glycerolum, saccharinum natricum, carmellosum natricum, dinatrii phosphas dihydricus, E 218 1 mg, propylis parahydroxybenzoas 0.2 mg, ethanolum 8.16 mg, aromatica (cerise) cum alcohol benzylicus, menthae piperitae aetheroleum, cinnamaldehydum, natrii hydroxidum, acidum hydrochloridum, aqua purificata ad suspensionem pro 1 ml corresp. natrium max. 0.78 mg.
Packungsbestandteile
suspension buvable/buccale 
  
 
Active AgentDose
Nystatine100000 UI/ml
BAG: Active AgentDose
Nystatine100000 UI
 
Inactive agentsDoseadditional_information
Acidum Hydrochloridum  
Aromatica (Cerise) cum Alcohol Benzylicus  
Carmellose Sodium  
Cinnamaldehydum  
Disodium Phosphate Dihydrate  
E 2181 mg/mlconserv.
Ethanol8.16 mg/ml 
Glycerol  
Menthae Piperitae Aetheroleum  
Sodium Hydroxide  
Propylis Parahydroxybenzoas0.2 mg/ml 
Saccharinum Natricum  
Saccharum500 mg/ml 
 
Source
Data was imported : 12.03.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home